(Q36577330)

15 August 2017

1 reference

title

Methylprednisolone and other confounders to spinal cord injury clinical trials (English)

1 reference

15 August 2017

1 reference

Marca L Sipski

1

1 reference

15 August 2017

Damien D Pearse

series ordinal

2

1 reference

15 August 2017

publication date

1 August 2006

1 reference

Nature Clinical Practice Neurology

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

402-403

1 reference

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Measurements and recovery patterns in a multicenter study of acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Current status of clinical trials for acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: an experimental study in the rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Inflammation and apoptosis: linked therapeutic targets in spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Inflammatory-mediated injury and repair in the traumatically injured spinal cord

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0221

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0221

1 reference

release_ir2e6gbobvg7jmbqnwx5ms2hjq

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ir2e6gbobvg7jmbqnwx5ms2hjq

24 November 2022

mapped directly with Wikidata item

1 reference